COVID-19 vaccination concerns among elderly people in Hong Kong


Submitted: 20 January 2021
Accepted: 25 January 2021
Published: 23 February 2021
Abstract Views: 2916
PDF: 585
HTML: 3
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Siukan Law Department of Science, School of Science and Technology, The Open University of Hong Kong, Ho Man Tin, Kowloon, Hong Kong, China.
  • Albert Wingnang Leung School of Graduate Studies, Lingnan University, Tuen Mun, Hong Kong, China.
  • Chuanshan Xu Key Laboratory of Molecular Target and Clinical Pharmacology, State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Not available


The Government of the Hong Kong Special Administrative Region. Government announces latest development of COVID-19 vaccine procurement; 12 December 2020. Available from: https://www.info.gov.hk/gia/general/202012/12/P2020121200031.htm. Accessed: 21 December 2020.

Bridle BW, Sharif S. Why vaccines are less effective in the elderly, and what it means for COVID-19? 21 July 2020. Available from: https://theconversation.com/whyvaccines-are-less-effective-in-theelderly-and-what-it-means-for-covid-19-141971. Accessed: 21 December 2020.

Gallagher J. Covid vaccine: First 'milestone' vaccine offers 90% protection; 9 November 2020. Available from: https://www.bbc.com/news/health-54873105. Accessed: 21 December 2020.

Reuters. Early data show two doses of Oxford/AstraZeneca vaccine provoked good immune response; 18 December 2020. Available from: https://www.reuters.com/article/ukhealth-coronavirus-astrazeneca-oxfordidUKKBN28R2J8. Accessed: 21 December 2020.

Polack FP, Thomas SJ, Kitchin N, et al.; C4591001 Clinical Trial Group. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020 [Epub ahead of print]. DOI: https://doi.org/10.1101/2021.07.28.21261159

Law, S., Leung, A. W. ., & Xu, C. . (2021). COVID-19 vaccination concerns among elderly people in Hong Kong. Geriatric Care, 7(1). https://doi.org/10.4081/gc.2021.9629

Downloads

Download data is not yet available.

Citations